The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease

    loading  Checking for direct PDF access through Ovid

Abstract

There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.

Related Topics

    loading  Loading Related Articles